EGFR and lung carcinoma: Through the meta-analyses of gene-expression difference in tumor vs. normal, in ADC vs. SQCC, and in mutants vs. WT for EGFR or KRAS as well as the meta-analyses of survival association and gene–gene correlation, we present multiple lines of evidence generated from our lung cancer database to strengthen the existing findings.